IL89166A0 - Pharmaceutical compositions comprising insulin-like growth factor i - Google Patents

Pharmaceutical compositions comprising insulin-like growth factor i

Info

Publication number
IL89166A0
IL89166A0 IL8989166A IL8916689A IL89166A0 IL 89166 A0 IL89166 A0 IL 89166A0 IL 8989166 A IL8989166 A IL 8989166A IL 8916689 A IL8916689 A IL 8916689A IL 89166 A0 IL89166 A0 IL 89166A0
Authority
IL
Israel
Prior art keywords
insulin
pharmaceutical compositions
growth factor
growth
factor
Prior art date
Application number
IL8989166A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Priority to IL10477789A priority Critical patent/IL104777A/en
Publication of IL89166A0 publication Critical patent/IL89166A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL8989166A 1988-02-05 1989-02-03 Pharmaceutical compositions comprising insulin-like growth factor i IL89166A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL10477789A IL104777A (en) 1988-02-05 1989-02-03 Pharmaceutical preparations containing insulin-like growth factor I

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88810072 1988-02-05

Publications (1)

Publication Number Publication Date
IL89166A0 true IL89166A0 (en) 1989-09-10

Family

ID=8200571

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8989166A IL89166A0 (en) 1988-02-05 1989-02-03 Pharmaceutical compositions comprising insulin-like growth factor i

Country Status (13)

Country Link
US (1) US4988675A (ko)
EP (1) EP0331630B1 (ko)
JP (1) JP2831017B2 (ko)
KR (1) KR0131087B1 (ko)
AU (1) AU624595B2 (ko)
CA (1) CA1336815C (ko)
DE (1) DE68905205T2 (ko)
DK (1) DK169233B1 (ko)
IE (1) IE63163B1 (ko)
IL (1) IL89166A0 (ko)
NZ (1) NZ227857A (ko)
PH (1) PH26085A (ko)
ZA (1) ZA89855B (ko)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440928B1 (en) 1988-12-06 2002-08-27 Colorado State University Research Foundation Method for treating diabetic neuropathy with NGF
GB8920381D0 (en) * 1989-09-08 1989-10-25 Greater Glasgow Health Board Treatment of insulin-resistant diabetes
US5128320A (en) * 1990-01-18 1992-07-07 Genentech, Inc. Method of restoring normal growth, weight gain or lean body mass in patients with glucocorticoid excess by administering igf-i
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
SE9100099D0 (sv) * 1991-01-11 1991-01-11 Kabi Pharmacia Ab Use of growth factor
SE9201573D0 (sv) * 1992-05-19 1992-05-19 Kabi Pharmacia Ab Use of igf-1
EP0602210A1 (en) * 1992-06-08 1994-06-22 Pharmacia AB (reg.number 556131-9608) Use of growth factor igf-i and/or igf-ii
US20070078089A1 (en) * 1992-07-06 2007-04-05 Ishii Douglas N Method for effecting changes in the central nervous system by administration of IGF-I or IGF-II
MD1486G2 (ro) * 1992-10-29 2001-11-30 Genentech, Inc. Metodă de tratament sau profilaxie a obezităţii
WO1994016722A1 (en) * 1993-01-25 1994-08-04 The Beth Israel Hospital Association Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties
US5446024A (en) * 1993-12-17 1995-08-29 Genentech, Inc. Purification of insulin-like growth factor
SE9402331D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab New use
SE9402370D0 (sv) * 1994-07-04 1994-07-04 Pharmacia Ab Use of IGF-I
US5728676A (en) * 1994-09-08 1998-03-17 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
US5565428A (en) * 1995-05-22 1996-10-15 Genentech, Inc. Method of administration of IGF-I
US5741776A (en) * 1995-05-22 1998-04-21 Genentech, Inc. Method of administration of IGF-I
EP0766966A3 (en) * 1995-09-08 2001-02-28 Eli Lilly And Company Method of treating insulin resistance
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6025368A (en) * 1997-02-25 2000-02-15 Celtrix Pharmaceuticals, Inc. Method for treating the symptoms of chronic stress-related disorders using IGF
US6514937B1 (en) 1997-02-25 2003-02-04 Celtrix Pharmaceuticals, Inc. Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
US6015786A (en) * 1997-02-25 2000-01-18 Celtrix Pharmaceuticals, Inc. Method for increasing sex steroid levels using IGF or IGF/IGFBP-3
US5916569A (en) * 1997-03-26 1999-06-29 E. Martin Spencer Human erectile dysfunction and methods of treatment
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
DK1141014T3 (da) * 1999-01-06 2005-04-11 Genentech Inc Insulinlignende vækstfaktor (IGF) i mutantvariant
DK1165119T3 (da) 1999-04-08 2003-12-15 Genentech Inc Sammensætning baseret på modsat ladede polypeptider
US6040292A (en) * 1999-06-04 2000-03-21 Celtrix Pharmaceuticals, Inc. Methods for treating diabetes
AU5760900A (en) * 1999-06-25 2001-01-31 Minimed, Inc. Multiple agent diabetes therapy
ES2301547T3 (es) 2000-05-16 2008-07-01 Genentech, Inc. Tratamiento de trastornos del cartilago.
AU8844301A (en) * 2000-08-29 2002-03-13 Univ Colorado State Res Found Method for treating the central nervous system by administration of igf structural analogs
HUP0500733A3 (en) * 2001-02-09 2010-01-28 Genentech Inc Crystallization of igf-1
WO2002067969A2 (en) 2001-02-21 2002-09-06 Medtronic Minimed, Inc. Stabilized insulin formulations
US7071300B2 (en) * 2001-03-14 2006-07-04 Genentech, Inc. IGF antagonist peptides
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
DE10316583A1 (de) 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
JP5108303B2 (ja) * 2003-08-21 2012-12-26 テルシカ インコーポレーティッド インスリン様成長因子（ｉｇｆ−ｉ）のレベル上昇による内臓脂肪の低下方法
EP1791551B1 (en) * 2004-08-30 2020-02-26 Ipsen Biopharmaceuticals, Inc. Method and device for diagnosing and treating insulin-like growth factor deficiency disorders
KR102288366B1 (ko) * 2018-03-09 2021-08-10 경북대학교 산학협력단 한속단 추출물을 유효성분으로 포함하는 비만 예방 또는 치료용 약학적 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3486216T2 (de) * 1983-04-25 1994-02-17 Chiron Corp Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren.

Also Published As

Publication number Publication date
CA1336815C (en) 1995-08-29
JPH01233227A (ja) 1989-09-19
DE68905205T2 (de) 1993-07-22
IE63163B1 (en) 1995-03-22
DK52189D0 (da) 1989-02-03
DE68905205D1 (de) 1993-04-15
IE890357L (en) 1989-08-05
KR890012667A (ko) 1989-09-18
KR0131087B1 (ko) 1998-04-17
AU2899989A (en) 1989-08-10
AU624595B2 (en) 1992-06-18
ZA89855B (en) 1989-10-25
PH26085A (en) 1992-02-06
US4988675A (en) 1991-01-29
DK169233B1 (da) 1994-09-19
EP0331630A1 (en) 1989-09-06
DK52189A (da) 1989-08-06
EP0331630B1 (en) 1993-03-10
JP2831017B2 (ja) 1998-12-02
NZ227857A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
IL89166A0 (en) Pharmaceutical compositions comprising insulin-like growth factor i
GB2222772B (en) Pharmaceutical compositions
GB2219940B (en) Pharmaceutical compositions
ZA894344B (en) Stable pharmaceutical composition
HU896876D0 (en) Pharmaceutical compositions
GB8825892D0 (en) Pharmaceutical composition
IL104777A0 (en) Pharmaceutical compositions comprising insulin-like growth factor i
NZ268125A (en) Growth hormone pharmaceutical composition
GB2217202B (en) Trimelamol-containing pharmaceutical compositions
ZA9017B (en) Pharmaceutical compositions
GB8808117D0 (en) Pharmaceutical compositions
GB8809225D0 (en) Pharmaceutical compositions
GB8830169D0 (en) Pharmaceutical compositions
GB8830174D0 (en) Pharmaceutical compositions
GB8822603D0 (en) Pharmaceutical compositions
GB8822507D0 (en) Pharmaceutical compositions
GB8820265D0 (en) Pharmaceutical compositions
GB8815444D0 (en) Pharmaceutical compositions
GB8815443D0 (en) Pharmaceutical compositions
GB8814146D0 (en) Pharmaceutical compositions
GB8809840D0 (en) Pharmaceutical compositions
IE882176L (en) Pharmaceutical compositions
GB8809650D0 (en) Pharmaceutical compositions
GB8826289D0 (en) Pharmaceutical compositions
ZA893224B (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
KB Patent renewed